Search
6 result(s) for 'author#Jörg Heil' within BMC
Page 1 of 1
Sort by: Relevance | Date
-
Citation: World Allergy Organization Journal 2012 5(Suppl 2):275
-
Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)
Fatigue is one of the most common and distressing side-effects of breast cancer radiotherapy. According to current guidelines, accelerated partial breast irradiation (APBI) may be considered as an alternative ...
Citation: Radiation Oncology 2020 15:134 -
The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
In metastatic breast cancer (MBC), antigen profiles of metastatic tissue and primary tumor differ in up to 20 % of patients. Reassessment of predictive markers, including human epidermal growth factor receptor...
Citation: BMC Cancer 2015 15:403 -
Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients
To prospectively assess circulating tumor cell (CTC) status at baseline (CTCBL) and after one cycle of a new line of systemic therapy (CTC1C), and changes from CTCBL to CTC1C (CTC kinetics, CTCKIN) for their util...
Citation: BMC Cancer 2014 14:512 -
Refining scores based on patient reported outcomes – statistical and medical perspectives
Patient Reported Outcomes (PRO) are gaining more and more importance in the context of clinical trials. The assessment of PRO is frequently performed by questionnaires where the multiple items of a questionnai...
Citation: BMC Medical Research Methodology 2019 19:167 -
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
In Germany, most breast cancer patients are treated in specialized breast cancer units (BCU), which are certified, and routinely monitored. Herein, we evaluate up-to-date oncological outcome of breast cancer (...
Citation: BMC Cancer 2016 16:734